News
Publications
Multimedia
Conferences
Webcasts
Resources
Subscribe

Spotlight -

Drug Development|

Quality Systems

Jaime Marach

Jaime Marach is member of USP Analytical Procedure Life Cycle Joint Subcommittee.

Articles by Jaime Marach

Paulista/stock.adobe.com – For high-risk analytical procedures, control-chart monitoring of selected performance data can provide early warning of changes in performance.

Ongoing Analytical Procedure Performance Verification—Stage 3 of USP<1220>

ByPhil Borman,Amanda Guiraldelli Mahr,Jane Weitzel,Sarah Thompson,Joachim Ermer,Stephanie Sproule,Jean-Marc Roussel,Jaime Marach,Horacio Pappa

March 2nd 2023

Analytical procedure performance can be continually verified by risk-based monitoring of performance related data.

Latest Updated Articles

Ongoing Analytical Procedure Performance Verification—Stage 3 of USP<1220>
Published: March 2nd 2023 | Updated:

Trending on Pharmaceutical Technology

Challenges for the Global Manufacturing of Vaccines

Integrating Sustainability into the Core of Pharmaceutical Science

Everything to Know About Pharmaceutical Tariffs in 2025

Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt

Outsourcing Partners Providing End-to-End Service

© 2025 MJH Life Sciences^®

All rights reserved.